Cargando…

Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)

This study was performed to assess the effect of chronic low-dose sitagliptin, a dipeptidyl peptidase 4 inhibitor, on metabolic profile and on renal lesions aggravation in a rat model of type-2 diabetic nephropathy, the Zucker diabetic fatty (ZDF) rat. Diabetic and obese ZDF (fa/fa) rats and their c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mega, Cristina, Teixeira de Lemos, Edite, Vala, Helena, Fernandes, Rosa, Oliveira, Jorge, Mascarenhas-Melo, Filipa, Teixeira, Frederico, Reis, Flávio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235777/ https://www.ncbi.nlm.nih.gov/pubmed/22203828 http://dx.doi.org/10.1155/2011/162092

Ejemplares similares

Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties
por: Mega, Cristina, et al.
Publicado: (2014)

Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
por: Mega, Cristina, et al.
Publicado: (2017)

Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
por: Ferreira, Liliana, et al.
Publicado: (2010)

Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
por: Marques, Catarina, et al.
Publicado: (2014)

Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A “Me Too” or “the Special One” Antidiabetic Class?
por: Godinho, Ricardo, et al.
Publicado: (2015)

Differential Effects of Acute (Extenuating) and Chronic (Training) Exercise on Inflammation and Oxidative Stress Status in an Animal Model of Type 2 Diabetes Mellitus
por: Teixeira de Lemos, Edite, et al.
Publicado: (2011)

Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties
por: Teixeira-Lemos, Edite, et al.
Publicado: (2011)

Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
por: Zhang, Minchun, et al.
Publicado: (2019)

Markers of Increased Cardiovascular Risk in Postmenopausal Women: Focus on Oxidized-LDL and HDL Subpopulations
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

New Markers of Early Cardiovascular Risk in Multiple Sclerosis Patients: Oxidized-LDL Correlates with Clinical Staging
por: Palavra, Filipe, et al.
Publicado: (2013)

The Heme Oxygenase System Suppresses Perirenal Visceral Adiposity, Abates Renal Inflammation and Ameliorates Diabetic Nephropathy in Zucker Diabetic Fatty Rats
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
por: Wang, Dongdong, et al.
Publicado: (2018)

Conversion to Sirolimus Ameliorates Cyclosporine-Induced Nephropathy in the Rat: Focus on Serum, Urine, Gene, and Protein Renal Expression Biomarkers
por: Sereno, José, et al.
Publicado: (2014)

Regular Physical Exercise as a Strategy to Improve Antioxidant and Anti-Inflammatory Status: Benefits in Type 2 Diabetes Mellitus
por: Teixeira de Lemos, Edite, et al.
Publicado: (2012)

Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle
por: van den Brom, Charissa E, et al.
Publicado: (2010)

Cognitive Performance during the Development of Diabetes in the Zucker Diabetic Fatty Rat
por: Spoelder, Marcia, et al.
Publicado: (2023)

Coenzyme A and Its Thioester Pools in Obese Zucker and Zucker Diabetic Fatty Rats
por: Chohnan, Shigeru, et al.
Publicado: (2020)

RNA-Seq Analysis of the Liver Transcriptome Reveals the Networks Regulating Treatment of Sitagliptin Phosphate plus Fuzhujiangtang Granule in the Zucker Diabetic Fatty Rats
por: Guo, Xuan, et al.
Publicado: (2020)

Histological Evaluation of Diabetic Neurodegeneration in the Retina of Zucker Diabetic Fatty (ZDF) Rats
por: Szabó, Klaudia, et al.
Publicado: (2017)

Pharmacist Intervention in Portuguese Older Adult Care
por: Rodrigues, Ana Rita, et al.
Publicado: (2022)

KIOM-79, an Inhibitor of AGEs–Protein Cross-linking, Prevents Progression of Nephropathy in Zucker Diabetic Fatty Rats
por: Kim, Young Sook, et al.
Publicado: (2011)

Elevated pulmonary arterial pressure in Zucker diabetic fatty rats
por: Morales-Cano, Daniel, et al.
Publicado: (2019)

Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats
por: Lezcano, Eduardo J, et al.
Publicado: (2014)

Effect of KIOM-79 on Diabetes-Induced Myocardial Fibrosis in Zucker Diabetic Fatty Rats
por: Kim, Junghyun, et al.
Publicado: (2013)

Preventive effects of Morus alba L. anthocyanins on diabetes in Zucker diabetic fatty rats
por: SARIKAPHUTI, ARIYA, et al.
Publicado: (2013)

Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2012)

The Relationship between Nutritional Status and Functional Capacity: A Contribution Study in Institutionalised Portuguese Older Adults
por: Caçador, Catarina, et al.
Publicado: (2021)

Dynamic Development of Fecal Microbiome During the Progression of Diabetes Mellitus in Zucker Diabetic Fatty Rats
por: Zhou, Wen, et al.
Publicado: (2019)

Anti-Obesity Effects of Onion Extract in Zucker Diabetic Fatty Rats
por: Yoshinari, Orie, et al.
Publicado: (2012)

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
por: Sui, Yi, et al.
Publicado: (2019)

Sitagliptin–Moringa oleifera coadministration did not delay the progression nor ameliorated functional and morphological anomalies in alloxan-induced diabetic nephropathy
por: Olurishe, Comfort Omoigemete, et al.
Publicado: (2017)

Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat
por: VanHoose, Lisa, et al.
Publicado: (2010)

Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats
por: Baynes, John, et al.
Publicado: (2009)

A Novel Rat Model of Type 2 Diabetes: The Zucker Fatty Diabetes Mellitus ZFDM Rat
por: Yokoi, Norihide, et al.
Publicado: (2013)

Cardiac β-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses
por: Haley, James M., et al.
Publicado: (2015)

Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model
por: Hjortbak, Marie Vognstoft, et al.
Publicado: (2018)

Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats
por: Delic, Denis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fblll031nouib1otq8v6jo6iq5